|
1
|
Thanasupawat T, Hammje K, Adham I, Ghia
JE, Del Bigio MR, Krcek J, Hoang-Vu C, Klonisch T and
Hombach-Klonisch S: INSL5 is a novel marker for human
enteroendocrine cells of the large intestine and neuroendocrine
tumours. Oncol Rep. 29:149–154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davar J, Connolly HM, Caplin ME, Pavel M,
Zacks J, Bhattacharyya S, Cuthbertson DJ, Dobson R,
Grozinsky-Glasberg S, Steeds RP, et al: Diagnosing and managing
carcinoid heart disease in patients with neuroendocrine tumors: An
expert statement. J Am Coll Cardiol. 69:1288–1304. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zavras N, Schizas D, Machairas N, Damaskou
V, Economopoulos N and Machairas A: Carcinoid syndrome from a
carcinoid tumor of the pancreas without liver metastases: A case
report and literature review. Oncol Lett. 13:2373–2376. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhattacharyya S, Davar J, Dreyfus G and
Caplin ME: Carcinoid heart disease. Circulation. 116:2860–2865.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Comaru-Schally AM and Schally AV: A
clinical overview of carcinoid tumors: Perspectives for improvement
in treatment using peptide analogs (Review). Int J Oncol.
26:301–309. 2005.PubMed/NCBI
|
|
6
|
Connolly HM, Schaff HV, Abel MD, Rubin J,
Askew JW, Li Z, Inda JJ, Luis SA, Nishimura RA and Pellikka PA:
Early and late outcomes of surgical treatment in carcinoid heart
disease. J Am Coll Cardiol. 66:2189–2196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhattacharyya S, Toumpanakis C, Burke M,
Taylor AM, Caplin ME and Davar J: Features of carcinoid heart
disease identified by 2- and 3-dimensional echocardiography and
cardiac MRI. Circ Cardiovasc Imaging. 3:103–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Amano Y, Mandai M, Baba T, Hamanishi J,
Yoshioka Y, Matsumura N and Konishi I: Recurrence of a carcinoid
tumor of the ovary 13 years after the primary surgery: A case
report. Oncol Lett. 6:1241–1244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pellikka PA, Tajik AJ, Khandheria BK,
Seward JB, Callahan JA, Pitot HC and Kvols LK: Carcinoid heart
disease. Clinical and echocardiographic spectrum in 74 patients.
Circulation. 87:1188–1196. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mansencal N, Mitry E, Forissier JF, Martin
F, Redheuil A, Lepère C, Farcot JC, Joseph T, Lacombe P, Rougier P,
et al: Assessment of patent foramen ovale in carcinoid heart
disease. Am Heart J. 151:1129.e1–1129.e6. 2006. View Article : Google Scholar
|
|
11
|
Zoghbi WA, Adams D, Bonow RO,
Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J,
Lang RM, et al: Recommendations for noninvasive evaluation of
native valvular regurgitation. J Am Soc Echocardiogr. 30:303–371.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haugaa KH, Bergestuen DS, Sahakyan LG,
Skulstad H, Aakhus S, Thiis-Evensen E and Edvardsen T: Evaluation
of right ventricular dysfunction by myocardial strain
echocardiography in patients with intestinal carcinoid disease. J
Am Soc Echocardiogr. 24:644–650. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Castillo JG, Silvay G and Solís J: Current
concepts in diagnosis and perioperative management of carcinoid
heart disease. Semin Cardiothorac Vasc Anesth. 17:212–223. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mollet NR, Dymarkowski S and Bogaert J:
MRI and CT revealing carcinoid heart disease. Eur Radiol.
13:L14–L18. 2003. View Article : Google Scholar
|
|
15
|
Dobson R, Burgess MI, Pritchard DM and
Cuthbertson DJ: The clinical presentation and management of
carcinoid heart disease. Int J Cardiol. 173:29–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dobson R, Burgess MI, Valle JW, Pritchard
DM, Vora J, Wong C, Chadwick C, Keevi B, Adaway J, Hofmann U, et
al: Serial surveillance of carcinoid heart disease: Factors
associated with echocardiographic progression and mortality. Br J
Cancer. 111:1703–1709. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tantu M, Belu E, Bobescu E, Armean SM,
Armean P, Constantin MM and Domnariu CD: Role of angiotensin
converting enzyme (ACE) inhibitors in hypertension and
cardiovascular protection management. Farmacia. 62:443–451.
2014.
|
|
18
|
Edwards NC, Yuan M, Nolan O, Pawade TA,
Oelofse T, Singh H, Mehrzad H, Zia Z, Geh JI, Palmer DH, et al:
Effect of valvular surgery in carcinoid heart disease: An
observational cohort study. J Clin Endocrinol Metab. 101:183–190.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hassan SA, Banchs J, Iliescu C, Dasari A,
Lopez-Mattei J and Yusuf SW: Carcinoid heart disease. Heart.
103:1488–1495. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pavel ME, Hainsworth JD, Baudin E, Peeters
M, Hörsch D, Winkler RE, Klimovsky J, Lebwohl D, Jehl V, Wolin EM,
et al RADIANT-2 Study Group, : Everolimus plus octreotide
long-acting repeatable for the treatment of advanced neuroendocrine
tumours associated with carcinoid syndrome (RADIANT-2): A
randomised, placebo-controlled, phase 3 study. Lancet.
378:2005–2012. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kulke MH, O'Dorisio T, Phan A, Bergsland
E, Law L, Banks P, Freiman J, Frazier K, Jackson J, Yao JC, et al:
Telotristat etiprate, a novel serotonin synthesis inhibitor, in
patients with carcinoid syndrome and diarrhea not adequately
controlled by octreotide. Endocr Relat Cancer. 21:705–714. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Connolly HM, Nishimura RA, Smith HC,
Pellikka PA, Mullany CJ and Kvols LK: Outcome of cardiac surgery
for carcinoid heart disease. J Am Coll Cardiol. 25:410–416. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Manoly I, McAnelly SL, Sriskandarajah S
and McLaughlin KE: Prognosis of patients with carcinoid heart
disease after valvular surgery. Interact Cardiovasc Thorac Surg.
19:302–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Patel C, Mathur M, Escarcega RO and Bove
AA: Carcinoid heart disease: Current understanding and future
directions. Am Heart J. 167:789–795. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mortelmans P, Herregods MC, Rega F and
Timmermans P: The path to surgery in carcinoid heart disease: A
retrospective study and a multidisciplinary proposal of a new
algorithm. Acta Cardiol. Jun 18–2018.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gustafsson BI, Hauso O, Drozdov I, Kidd M
and Modlin IM: Carcinoid heart disease. Int J Cardiol. 129:318–324.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luis SA and Pellikka PA: Carcinoid heart
disease: Diagnosis and management. Best Pract Res Clin Endocrinol
Metab. 30:149–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arghami A, Connolly HM, Abel MD and Schaff
HV: Quadruple valve replacement in patients with carcinoid heart
disease. J Thorac Cardiovasc Surg. 140:1432–1434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wilhelmi M, Fritz MK, Fischer S, Haverich
A and Harringer W: Triple valve replacement in a patient with
severe carcinoid heart disease. Cardiovasc Surg. 10:287–290. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mokhles P, van Herwerden LA, de Jong PL,
de Herder WW, Siregar S, Constantinescu AA, van Domburg RT and
Roos-Hesselink JW: Carcinoid heart disease: Outcomes after surgical
valve replacement. Eur J Cardiothorac Surg. 41:1278–1283. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ridker PM, Chertow GM, Karlson EW, Neish
AS and Schoen FJ: Bioprosthetic tricuspid valve stenosis associated
with extensive plaque deposition in carcinoid heart disease. Am
Heart J. 121:1835–1838. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schaefer A, Sill B, Schoenebeck J,
Schneeberger Y, Reichenspurner H and Gulbins H: Failing stentless
bioprostheses in patients with carcinoid heart valve disease. J
Cardiothorac Surg. 10:412015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Heidecker B, Moore P, Bergsland EK,
Merrick SH and Rao RK: Transcatheter pulmonic valve replacement in
carcinoid heart disease. Eur Heart J Cardiovasc Imaging.
16:10462015.PubMed/NCBI
|
|
34
|
Khan JN, Doshi SN, Rooney SJ, Bhabra MS
and Steeds RP: Transcatheter pulmonary and tricuspid valve-in-valve
replacement for bioprosthesis degeneration in carcinoid heart
disease. Eur Heart J Cardiovasc Imaging. 17:1142016.PubMed/NCBI
|
